Clinical Trial Update: Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PF-04523655 versus laser treatment in diabetic macular edema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• PF-04523655

Snippet

Sponsor: Quark Pharmaceuticals | Conditions: Diabetic Retinopathy, Diabetes Complications | Phase 2 | Status: TERMINATED